Metabolic side effects have included osteolytic-induced hypercalcemia in immobilized patients or those with metastatic breast disease. Anabolic steroids affect electrolyte balance, nitrogen retention, and urinary calcium excretion. Edema, with and without congestive heart failure, has occurred during anabolic steroid therapy. Decreased glucose tolerance requiring adjustments in hyperglycemic control has been noted in diabetic patients. The androgenic activity of anabolic steroids may decrease levels of thyroxin-binding globulin and result in decreased total T4 serum levels and increased resin uptake of T3 and T4. Free thyroid hormone levels remain unchanged and there is no clinical evidence of thyroid dysfunction. Significant increases in low density lipoproteins (LDL) and decreases in high density lipoproteins (HDL) have occurred. [ Ref ]
Pharmacom Labs Oxandrolonos is presented in a 100 tablet box with 2 blister packs of 50 tablets each. Each tablet reportedly contains 10 milligrams of oxandrolone according to the label and packaging. Samples of this product were purchased from a North American-based authorized distributor between the dates of June 1, 2015 and June 30, 2015. The samples were forwarded and received by the analytical laboratory SIMEC AG for HPLC-UV testing on July 20, 2015. The quantitative dosage testing report was completed on August 10, 2015. The product was identified with an expiration date of October 15, 2018 and a batch number of MBMN1. There was no verification code printed on the box.